Elif Ozkok
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elif Ozkok has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
A. Aksu
1 shared publication- Ahmet Ata Alturfan
Istanbul University-Cerrahpasa
1 shared publication - Ahmet Ozaydin
Department of Medical Biology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey
1 shared publication - Arzu Ergen
Department of Radiation Oncology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey
1 shared publication - Aysen Yarat
Marmara University
1 shared publication - Ayşe Ogan
Marmara University
1 shared publication
Latest Publications
- Open Access
- 28 September 2022
- Published by Academician Publishing
Biyokimyada Temel ve Özel Konular
Biyokimya, canlı sistemde gerçekleşen kimyasal olayları, bu sistemde yer alan tüm moleküllerin yapısını, bileşimini ve fonksiyonunu inceleyen bir bilim dalıdır. Temel biyokimya, biyokimyasal mekanizmaların moleküler düzeyde anlaşılması için alt yapıyı oluştururken hastalıklar ve tedavilerin öğrenilmesini kolaylaştırmaktadır. Biyokimyasal olayların normal bir şekilde gerçekleşmesi sağlığımızın temelini oluşturmakta; bu sistemin bozulması ile hastalıklar ortaya çıkmakta, hastalıklar için uygun ilaçların geliştirilmesi, kullanılması ve hastalıkların tedavi süreci başlamaktadır.
- 28 September 2022
- Published by Academician Publishing
Open AccessBiyokimyada Temel ve Özel Konular
Biyokimya, canlı sistemde gerçekleşen kimyasal olayları, bu sistemde yer alan tüm moleküllerin yapısını, bileşimini ve fonksiyonunu inceleyen bir bilim dalıdır. Temel biyokimya, biyokimyasal mekanizmaların moleküler düzeyde anlaşılması için alt yapıyı oluştururken hastalıklar ve tedavilerin öğrenilmesini kolaylaştırmaktadır. Biyokimyasal olayların normal bir şekilde gerçekleşmesi sağlığımızın temelini oluşturmakta; bu sistemin bozulması ile hastalıklar ortaya çıkmakta, hastalıklar için uygun ilaçların geliştirilmesi, kullanılması ve hastalıkların tedavi süreci başlamaktadır.
- 30 September 2016
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 65 (5) , 833-842
Amelioration of Energy Metabolism by Melatonin in Skeletal Muscle of Rats With LPS Induced Endotoxemia
In the literature, few studies have investigated the effects of melatonin on energy metabolism in skeletal muscle in endotoxemia. We investigated the effects of melatonin on tissue structure, energy metabolism in skeletal muscle, and antioxidant level of rats with endotoxemia. We divided rats into 4 groups, control, lipopolysaccharide (LPS) (20 mg/kg, i.p., single dose), melatonin (10 mg/kg, i.p., three times), and melatonin + LPS. Melatonin was injected i.p. 30 min before and after the 2nd and 4th hours of LPS injection. Antioxidant status was determined by glutathione (GSH) measurement in the blood. Muscle tissue was stained using modified Gomori trichrome (MGT), succinic dehydrogenase (SDH), and cytochrome oxidase (COX) and histological scored. Also the sections were then stained with hematoxylin and eosin. The stained sections were visualized and photographed. Creatine, creatine phosphate, adenosine triphosphate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP) levels were investigated using high performance liquid chromatography (HPLC) in muscle tissue. In the Melatonin + LPS group, blood GSH levels were increased compared with the LPS group (P<0.01). Melatonin reduced myopathic changes in the LPS group according to the histopathologic findings. In addition, ATP values were increased compared with the LPS group (P<0.05). Our findings showed melatonin treatment prevented muscle damage by increasing ATP and GSH levels in rats with LPS induced endotoxemia.
- 30 September 2016
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 65 (5) , 833-842
Amelioration of Energy Metabolism by Melatonin in Skeletal Muscle of Rats With LPS Induced Endotoxemia
In the literature, few studies have investigated the effects of melatonin on energy metabolism in skeletal muscle in endotoxemia. We investigated the effects of melatonin on tissue structure, energy metabolism in skeletal muscle, and antioxidant level of rats with endotoxemia. We divided rats into 4 groups, control, lipopolysaccharide (LPS) (20 mg/kg, i.p., single dose), melatonin (10 mg/kg, i.p., three times), and melatonin + LPS. Melatonin was injected i.p. 30 min before and after the 2nd and 4th hours of LPS injection. Antioxidant status was determined by glutathione (GSH) measurement in the blood. Muscle tissue was stained using modified Gomori trichrome (MGT), succinic dehydrogenase (SDH), and cytochrome oxidase (COX) and histological scored. Also the sections were then stained with hematoxylin and eosin. The stained sections were visualized and photographed. Creatine, creatine phosphate, adenosine triphosphate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP) levels were investigated using high performance liquid chromatography (HPLC) in muscle tissue. In the Melatonin + LPS group, blood GSH levels were increased compared with the LPS group (P<0.01). Melatonin reduced myopathic changes in the LPS group according to the histopathologic findings. In addition, ATP values were increased compared with the LPS group (P<0.05). Our findings showed melatonin treatment prevented muscle damage by increasing ATP and GSH levels in rats with LPS induced endotoxemia.
- 6 January 2012
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 16 (6) , 504-507
DNA Repair Genes in Parkinson's Disease
Aims: There is a growing interest in the understanding of a possible role of DNA repair systems in ageing and neurodegenerative diseases after DNA damage is observed in the brain of individuals affected by neurodegenerative diseases. In the light of these findings, we investigated whether DNA repair gene polymorphisms ( XRCC1 Arg399Gln, XRCC3 Thr241Met XPD Lys751Gln, XPG Asp1104His, APE1 Asp148Glu, and HOGG1 Ser326Cys ) account for an increased risk of Parkinson's disease (PD). Methods: The present analyses are based on 60 case subjects with PD and 108 unrelated healthy controls. Genotyping of DNA repair gene polymorphisms were detected by polymerase chain reaction-restriction fragment length polymorphism. Results: We, for the first time, demonstrated the positive association of APE1, XRCC1, and XRCC3 DNA repair gene variants with PD risk. In our study, the frequencies of Glu/Glu genotype in APE1, Gln+ genotype of XRCC1, and Thr+ genotype of XRCC3 are higher in patients than in controls ( p =0.028, p =0.002 and p =0.046, respectively). Conclusions: In conclusion, our findings have suggested that APE1, XRCC1, and XRCC3 genetic variants may be a risk factor by increasing oxidative stress that might cause the loss of dopaminergic cells in the substantiata nigra and locus caeruleus, leading to abnormal signal transmittion, and ultimately, the development of PD. In addition, generation of reactive oxygen species from dopamine might affect the other DNA repair pathway proteins that we did not examine in the current study. Further studies with larger sample groups are necessary to clarify the role of DNA repair genes and the development of PD.
- 6 January 2012
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 16 (6) , 504-507
DNA Repair Genes in Parkinson's Disease
Aims: There is a growing interest in the understanding of a possible role of DNA repair systems in ageing and neurodegenerative diseases after DNA damage is observed in the brain of individuals affected by neurodegenerative diseases. In the light of these findings, we investigated whether DNA repair gene polymorphisms ( XRCC1 Arg399Gln, XRCC3 Thr241Met XPD Lys751Gln, XPG Asp1104His, APE1 Asp148Glu, and HOGG1 Ser326Cys ) account for an increased risk of Parkinson's disease (PD). Methods: The present analyses are based on 60 case subjects with PD and 108 unrelated healthy controls. Genotyping of DNA repair gene polymorphisms were detected by polymerase chain reaction-restriction fragment length polymorphism. Results: We, for the first time, demonstrated the positive association of APE1, XRCC1, and XRCC3 DNA repair gene variants with PD risk. In our study, the frequencies of Glu/Glu genotype in APE1, Gln+ genotype of XRCC1, and Thr+ genotype of XRCC3 are higher in patients than in controls ( p =0.028, p =0.002 and p =0.046, respectively). Conclusions: In conclusion, our findings have suggested that APE1, XRCC1, and XRCC3 genetic variants may be a risk factor by increasing oxidative stress that might cause the loss of dopaminergic cells in the substantiata nigra and locus caeruleus, leading to abnormal signal transmittion, and ultimately, the development of PD. In addition, generation of reactive oxygen species from dopamine might affect the other DNA repair pathway proteins that we did not examine in the current study. Further studies with larger sample groups are necessary to clarify the role of DNA repair genes and the development of PD.